MX2009008025A - Heparinas que incluyen al menos un enlace covalente con biotina o un derivado de biotina, método para prepararlas y su uso. - Google Patents

Heparinas que incluyen al menos un enlace covalente con biotina o un derivado de biotina, método para prepararlas y su uso.

Info

Publication number
MX2009008025A
MX2009008025A MX2009008025A MX2009008025A MX2009008025A MX 2009008025 A MX2009008025 A MX 2009008025A MX 2009008025 A MX2009008025 A MX 2009008025A MX 2009008025 A MX2009008025 A MX 2009008025A MX 2009008025 A MX2009008025 A MX 2009008025A
Authority
MX
Mexico
Prior art keywords
biotin
covalent bond
heparins
preparing same
so3na
Prior art date
Application number
MX2009008025A
Other languages
English (en)
Inventor
Christian Viskov
Pierre Mourier
Philippe Hubert
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2009008025A publication Critical patent/MX2009008025A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Heparinas biotiniladas, caracterizadas porque los polisacáridos que constituyen dichas heparinas poseen en su extremo reductor, un enlace covalente con un grupo -(R1), -Biot y corresponden a la fórmula general (I): en la cual i es igual a 0 o 1, R1 representa una cadena de la fórmula -CO-(CH2)j-NH o -CO-(CH2)jNH-CO-(CH2)k-NH o j y k son enteros que pueden tener cualquier valor desde 1 hasta 10. Biot representa un grupo biotina o derivado de biotina, n representa un número entero que tiene un valor medio de aproximadamente 25 para una heparina de masa molecular media de 15 000 Da, X representa H o SO3Na, Y representa COCH3 o SO3Na, la línea ondulada representa una unión situada ya sea debajo o encima del ciclo piranósico al cual está unida. La invención también se refiere a un método para su preparación y a su uso en terapéutica.
MX2009008025A 2007-02-14 2008-02-12 Heparinas que incluyen al menos un enlace covalente con biotina o un derivado de biotina, método para prepararlas y su uso. MX2009008025A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0701053A FR2912408A1 (fr) 2007-02-14 2007-02-14 Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
PCT/FR2008/000172 WO2008113918A1 (fr) 2007-02-14 2008-02-12 Heparines comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine, leur procede de preparation et leur utilisation

Publications (1)

Publication Number Publication Date
MX2009008025A true MX2009008025A (es) 2009-08-07

Family

ID=38470146

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008025A MX2009008025A (es) 2007-02-14 2008-02-12 Heparinas que incluyen al menos un enlace covalente con biotina o un derivado de biotina, método para prepararlas y su uso.

Country Status (15)

Country Link
US (1) US20100075922A1 (es)
EP (1) EP2120970A1 (es)
JP (1) JP2010518251A (es)
KR (1) KR20090109105A (es)
CN (1) CN101605549A (es)
AR (1) AR065328A1 (es)
AU (1) AU2008228161A1 (es)
BR (1) BRPI0808070A2 (es)
CA (1) CA2678166A1 (es)
FR (1) FR2912408A1 (es)
IL (1) IL199880A0 (es)
MX (1) MX2009008025A (es)
RU (1) RU2009134160A (es)
TW (1) TW200902036A (es)
WO (1) WO2008113918A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101794877B1 (ko) * 2010-09-14 2017-11-07 고쿠리츠 다이가쿠 호징 미야자키 다이가쿠 고순도 헤파린 및 그 제조방법
CN103087218B (zh) * 2011-12-30 2016-01-20 北京大学 直链形肝素修饰的生物型人造血管
GB201415062D0 (en) * 2014-08-26 2014-10-08 Aplagon Oy Therapeutic
WO2018175464A1 (en) * 2017-03-20 2018-09-27 Rensselaer Polytechnic Institute Enzymatic preparation of increased anticoagulant bovine sourced heparin
KR102138366B1 (ko) 2017-12-11 2020-07-28 이강수 이중관 선단보강부를 이용하여 제작된 선단보강파일 및 그 시공방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874924B1 (fr) * 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique

Also Published As

Publication number Publication date
FR2912408A1 (fr) 2008-08-15
AR065328A1 (es) 2009-06-03
RU2009134160A (ru) 2011-03-20
TW200902036A (en) 2009-01-16
JP2010518251A (ja) 2010-05-27
AU2008228161A1 (en) 2008-09-25
IL199880A0 (en) 2010-04-15
WO2008113918A1 (fr) 2008-09-25
KR20090109105A (ko) 2009-10-19
EP2120970A1 (fr) 2009-11-25
US20100075922A1 (en) 2010-03-25
CN101605549A (zh) 2009-12-16
CA2678166A1 (fr) 2008-09-25
BRPI0808070A2 (pt) 2014-08-05

Similar Documents

Publication Publication Date Title
MX2009008025A (es) Heparinas que incluyen al menos un enlace covalente con biotina o un derivado de biotina, método para prepararlas y su uso.
MX2009006414A (es) Gomas gellan clarificadas de ultra alto desempeño.
NO20060587L (no) Silylesterkopolymerblandinger
BRPI0516875A (pt) composições de polìmeros reforçadas com fibras de vidro
MY142376A (en) Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
ATE479421T1 (de) Kationisches konditionierungsmittel
TW200603818A (en) Conjugates of hydroxyethyl starch and erythropoietin
MX2007003146A (es) Composiciones hidraulicas flexibles.
EA201101164A1 (ru) Иммуногенная композиция
TW200621779A (en) Process for the manufacture of dihydropteridinones
EP2447285A3 (en) Low molecular weight heparin composition and uses thereof
MX2007011668A (es) Mezclas de caucho de silicona de reticulacion por adicion autoadhesivas, metodo para la produccion de las mismas, metodo para producir partes moldeadas compuestas y uso de las mismas.
AU2003267416A1 (en) Production of suspensions of hydrophobic oxide particles
MY142018A (en) Thiophene derivatives as chk 1 inihibitors
ATE412703T1 (de) Sulfoniuminitiatoren, verfahren zur herstellung und verwendung für kationische polymerisierbare zusammensetzungen
MX2010000372A (es) Composiciones polimericas modificadas, proceso de modificacion y agentes generadores de radicales libres.
ATE507836T1 (de) 2-o, 3-o desulfatiertes heparin zur behandlung von heparininduzierter thrombozytopenie (hit)
BRPI0807981A2 (pt) Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso
WO2010056690A3 (en) Polymeric compositions and method of making and articles thereof
DE502007003544D1 (de) Verfahren zur herstellung von superabsorbern
ATE532804T1 (de) Neue rheologiemodifikatoren zur modifizierung des rheologischen verhaltens von beschichtungszusammensetzungen
DE60034250D1 (de) Verwendung von flüssigkeitsbeständigen silikonzusammensetzungen zum abdichten von magnesiumlegierungen
CY1121099T1 (el) Βιοτεχνολογικα θειωμενη θειικη χονδροϊτινη στη θεση 4 ή 6 στην ιδια αλυσιδα πολυσακχαριτη, και μεθοδος για την παρασκευη αυτης
TW200708591A (en) Aromatic graft polymer
MX2009005163A (es) Sistema espesante con ph regulable.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal